Ignite Creation Date:
2024-05-06 @ 10:27 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03264547
Status:
UNKNOWN
Last Update Posted:
2017-09-21
First Post:
2017-08-01
Brief Title:
A Study to Compare Eribulin Mesylate Pertuzumab Trastuzumab With Paclitaxel or Docetaxel Pertuzumab Trastuzumab
Sponsor:
Organization:
Japan Breast Cancer Research Group